Health Care Originals, the leading chronic respiratory disease management platform, is delighted to announce the appointment of Cameron Jacox as Strategic Growth Advisor. Jacox will join Nightingale’s team in this key role, which builds on his extensive contributions to the company thus far.
The team, led by Chief Executive Officer Sharon Samjitsingh, will leverage his expertise at scaling digital health startups and driving rapid growth. His proven experience will be instrumental as HCO scales the Nightingale platform to address the needs of individuals with asthma and chronic obstructive pulmonary disease (COPD).
Cameron Jacox believes, “This platform and team are finally creating solutions for those suffering from asthma or COPD, proving their clinical efficacy, and bringing them to market. From the smart, patented wearable to the reduced costs of care and access to respiratory therapists, the solution solves the biggest problems that these underserved populations face.”
“Cameron’s extensive experience scaling digital health companies from a marketing and go-to-market perspective makes him an invaluable addition to our team,” stated Sharon Samjitsingh, CEO and Co-Founder. “We are thrilled to have him deepen his role with us as we advance our mission of revolutionizing respiratory care, empowering individuals with asthma and COPD to live unencumbered by their condition. Our core technology, ADAMM, has already demonstrated widespread applicability beyond asthma and COPD, and we will continue to expand our Nightingale offering to valorize the richness of our digital biomarker capabilities. I can think of no one better suited than Cameron to help us grow to our full potential.”
The company’s Nightingale platform provides individuals with asthma or COPD access to clinically-validated virtual respiratory care. The centerpiece of their solution is ADAMM, a small and comfortable wearable device that seamlessly monitors essential lung health parameters as individuals go about their daily lives. ADAMM tracks parameters including cough, respiration rate, activity level, heart rate, and temperature. The data is wirelessly transferred to the user’s mobile device and Respiratory Therapist (RT), allowing their RT to monitor and understand their symptoms through Nightingale’s user-friendly app.
“As someone who has struggled with asthma since childhood, I understand how the fear of having an attack can inhibit daily life. And the toll it takes on peace of mind for everyone involved cannot be underestimated. We’re proud to be transforming members’ lives – with Nightingale, they understand their personal baselines and are empowered to manage their condition without fear, leading to outcomes and clear savings on the cost of care within 6 months,” concluded Sharon Samjitsingh.
About Health Care Originals (HCO)
Health Care Originals provides solutions that empower individuals to understand their bodies by developing unique digital biomarkers using its proprietary wearable. Its first wearable, ADAMM, has already collected over 1,000,000 data points, including ambulatory cough. HCO’s solutions for clinical trials and telemedicine use the power of ADAMM to revolutionize those spaces. HCO’s newest solution, Nightingale Digital Health, is at the forefront of virtual respiratory care, revolutionizing how individuals manage asthma and COPD. Their comprehensive platform combines the convenience of virtual consultations with respiratory therapists, ADAMM’s cutting-edge management technology, and a user-friendly app for personalized insights. Nightingale is dedicated to empowering individuals with respiratory conditions to take control of their health and enjoy a higher quality of life. To learn more about Health Care Originals and its original solutions, visit www.healthcareoriginals.com. For Nightingale Digital Health visit https://ndh.health.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230724107332/en/